Forward Pharma A/S

Chinese developers of advanced therapeutics, including cell and gene therapies, have continued to garner support from venture capital and private equity investors in the past weeks. Shanghai-based Epi

Medtronic & Aetna's Outcomes-Based Insulin Pump Deal Medtronic PLC and Aetna Inc. have signed an outcomes-based agreement regarding reimbursement of the medtech giant's self-adjusting insulin

Alkermes PLC has signed the most obvious partner for its late-stage multiple sclerosis drug, Biogen Inc. , in a deal that seems advantageous to both companies. The Phase III next-generation fumar

Acorda Therapeutics Inc. 's celebration in defeating Kyle Bass' challenge of its Ampyra (dalfampridine) patents in inter partes review (IPR) proceedings was short-lived as a district court found th